131 related articles for article (PubMed ID: 3028322)
1. Monitoring urine for inhaled cannabinoids.
Moffat AC
Arch Toxicol Suppl; 1986; 9():103-10. PubMed ID: 3028322
[TBL] [Abstract][Full Text] [Related]
2. Passive inhalation of cannabis smoke.
Law B; Mason PA; Moffat AC; King LJ; Marks V
J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
[TBL] [Abstract][Full Text] [Related]
4. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
[TBL] [Abstract][Full Text] [Related]
5. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
[TBL] [Abstract][Full Text] [Related]
6. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
7. Laboratory detection of marijuana use.
Schwartz RH; Hawks RL
JAMA; 1985 Aug; 254(6):788-92. PubMed ID: 2989570
[TBL] [Abstract][Full Text] [Related]
8. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
9. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9-tetrahydrocannabinol metabolites in human urine.
Williams PL; Moffat AC; King LJ
J Chromatogr; 1979 Dec; 186():595-603. PubMed ID: 232708
[TBL] [Abstract][Full Text] [Related]
10. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous enzyme immunoassay for cannabinoids in urine.
Rodgers R; Crowl CP; Eimstad WM; Hu MW; Kam JK; Ronald RC; Rowley GL; Ullman EF
Clin Chem; 1978 Jan; 24(1):95-100. PubMed ID: 338202
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
ElSohly MA; Jones AB; ElSohly HN
J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
[TBL] [Abstract][Full Text] [Related]
16. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
Goullé JP; Guerbet M
Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
[TBL] [Abstract][Full Text] [Related]
17. [Passive inhalation of cannabis smoke--is it detectable?].
Westin AA; Slørdal L
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):109-13. PubMed ID: 19151803
[TBL] [Abstract][Full Text] [Related]
18. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.
Grauwiler SB; Scholer A; Drewe J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):515-22. PubMed ID: 17236827
[TBL] [Abstract][Full Text] [Related]
19. The development of a radioimmunoassay for cannabinoids in blood and urine.
Teale JD; Forman EJ; King LJ; Piall EM; Marks V
J Pharm Pharmacol; 1975 Jul; 27(7):465-72. PubMed ID: 239149
[TBL] [Abstract][Full Text] [Related]
20. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]